Various embodiments of the invention provide human receptors and
membrane-associated proteins (REMAP) and polynucleotides which identify
and encode REMAP. Embodiments of the invention also provide expression
vectors, host cells, anti-bodies, agonists, and antagonists. Other
embodiments provide methods for diagnosing, treating, or preventing
disorders associated with aberrant expression of REMAP.
